FDA Inspection
Celgene International SarlCelgene International Sarl – FDA Inspection, Sep 15, 2017
Record Details
This FDA Inspection record concerns Celgene International Sarl, with an inspection on September 15, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 297260ba-3a39-4228-8ca4-e7527149ae6f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1026576
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.110(a)Control procedures to monitor and validate performance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Celgene International Sarl
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 16, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 25, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 8, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 4, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Celgene International Sarl
- FDA Inspection 1208191 - 2023-06-16
- FDA Inspection 854856 - 2013-10-25
- FDA Inspection 773948 - 2012-03-08
- FDA Inspection 618709 - 2009-09-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.